CHELSEA PROVENZANO: Open Payments
NPI 1033631700 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 52 payments from 15 companies in 2025. Trend: 2023 $447 · 2024 $1,071 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $273 |
| Novo Nordisk Inc | 12 | $260 |
| AstraZeneca Pharmaceuticals LP | 2 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Lilly USA, LLC | 3 | $57 |
| Lundbeck LLC | 2 | $45 |
| ABBVIE INC. | 2 | $34 |
| Exact Sciences Corporation | 1 | $25 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $24 |
Products named: AIRSUPRA, EVENITY, REXULTI, OTEZLA, JARDIANCE, Wegovy, Ozempic, Saxenda.
Industry payments across CA — which companies pay providers there.
